Erythropoietin
Full Form of EPO
What is EPO?
Erythropoietin (EPO) is a glycoprotein hormone primarily produced by the kidneys that stimulates the bone marrow to produce red blood cells. In India, synthetic EPO (e.g., epoetin alfa) is widely used to treat anemia associated with chronic kidney disease (CKD), cancer chemotherapy, and HIV therapy, especially in patients undergoing dialysis. It is also used off-label in surgical settings to reduce blood transfusion requirements. EPO is a key medication listed in India's National List of Essential Medicines, ensuring its availability in public health facilities. Beyond clinical use, EPO gained notoriety as a performance-enhancing drug in endurance sports like cycling and athletics, leading to its ban by the World Anti-Doping Agency (WADA). Indian athletes tested positive for EPO have faced suspensions, highlighting its relevance in sports medicine and ethics. In medical exams like NEET PG and AIIMS, questions frequently cover EPO's mechanism, indications, and adverse effects (e.g., hypertension, thrombosis). Its role in the hypoxia-inducible factor (HIF) pathway is a common topic in physiology and pharmacology. Understanding EPO is crucial for Indian medical students and practitioners managing anemia in CKD, which affects millions in the country.
EPO का फुल फॉर्म
एरिथ्रोपोइटिन
Example
The nephrologist prescribed subcutaneous EPO injections for the 55-year-old patient with stage 4 chronic kidney disease to maintain hemoglobin levels above 10 g/dL.